Whole exome sequencing identifies SCD5 as a novel causative gene for autosomal dominant nonsyndromic deafness.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
May 2020
Historique:
received: 25 11 2018
revised: 19 12 2019
accepted: 17 01 2020
pubmed: 24 1 2020
medline: 30 12 2020
entrez: 24 1 2020
Statut: ppublish

Résumé

We report a genetic assessment of autosomal dominant, nonsyndromic, progressive sensorineural hearing loss in a Chinese family, combining whole-exome sequencing and genome-wide linkage analysis. A novel missense mutation, c.626G > C, in the SCD5 gene was identified in this family. The heterozygous missense mutation could segregate hearing loss cases among family members, and was predicted to be deleterious by Polyphen-2, LRT and Mutation Taster. SCD5 is an endoplasmic reticulum enzyme, catalyzing the formation of monounsaturated fatty acids (MUFAs) from saturated fatty acids (SFAs). It plays a crucial role in regulating lipid metabolism. The SCD5 protein is expressed in inner and outer hair cells of the organ of Corti, the stria vascularis, cells of the lateral cochlear wall behind the spiral prominence, and more strongly in spiral ganglion cells of guinea pig and human fetal cochleas. SCD5 protein was also expressed in the brain, consistent with the hearing loss feature: the patients had a poor speech discrimination score at young age and mild hearing loss as evaluated by pure tone audiometry. In summary, we identified SCD5 as a novel gene responsible for autosomal dominant nonsyndromic deafness.

Identifiants

pubmed: 31972369
pii: S1769-7212(18)30870-X
doi: 10.1016/j.ejmg.2020.103855
pii:
doi:

Substances chimiques

SCD5 protein, human EC 1.14.19.1
Stearoyl-CoA Desaturase EC 1.14.19.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103855

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Xingxing Lu (X)

Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China.

Yanmei Zhang (Y)

Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China.

Li Chen (L)

Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China.

Qi Wang (Q)

Department of Otolaryngology, Head and Neck Surgery, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Zhen'gang Zeng (Z)

Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China.

Cheng Dong (C)

Taikang Insurance Group Inc., Beijing, China.

Yu Qi (Y)

Department of Central Laboratory, Peking University First Hospital, Beijing, China.

Yuhe Liu (Y)

Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China. Electronic address: liuyuhefeng@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH